Pathophysiology, diagnosis, and herbal medicine-based therapeutic implication of rheumatoid arthritis: an overview

被引:12
作者
Kaur, Charanjit [1 ]
Mishra, Yachana [2 ]
Kumar, Rajesh [1 ]
Singh, Gurvinder [1 ]
Singh, Sukhraj [3 ]
Mishra, Vijay [1 ]
Tambuwala, Murtaza M. [4 ]
机构
[1] Lovely Profess Univ, Sch Pharmaceut Sci, Phagwara 144411, Punjab, India
[2] Lovely Profess Univ, Sch Bioengn & Biosci, Phagwara 144411, Punjab, India
[3] Dept Food Civil Supply & Consumer Affairs, Amritsar 143001, Punjab, India
[4] Univ Lincoln, Lincoln Med Sch, Lincoln LN6 7TS, England
关键词
Rheumatoid arthritis; Bioimaging; Non-steroidal anti-inflammatory drug; Herbal medicine; COLLAGEN-INDUCED ARTHRITIS; NF-KAPPA-B; FIBROBLAST-LIKE SYNOVIOCYTES; ADJUVANT-INDUCED ARTHRITIS; WITHANIA-SOMNIFERA ROOT; DOUBLE-BLIND; PHASE-II; ANTIARTHRITIC ACTIVITY; MONOCLONAL-ANTIBODY; INADEQUATE RESPONSE;
D O I
10.1007/s10787-024-01445-8
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
071005 [微生物学]; 100108 [医学免疫学];
摘要
Rheumatoid arthritis (RA) stands as an autoimmune disorder characterized by chronic joint inflammation, resulting in profound physiological alterations within the body. Affecting approximately 0.4-1.3% of the global population, this condition poses significant challenges as current therapeutic approaches primarily offer symptomatic relief, with the prospect of complete recovery remaining elusive. This review delves into the contemporary advancements in understanding the pathophysiology, diagnosis, and the therapeutic potential of herbal medicine in managing RA. Notably, early diagnosis during the initial stages emerges as the pivotal determinant for successful recovery post-treatment. Utilizing tools such as Magnetic Resonance Imaging (MRI), anti-citrullinated peptide antibody markers, and radiography proves crucial in pinpointing the diagnosis of RA with precision. Unveiling the intricate pathophysiological mechanisms of RA has paved the way for innovative therapeutic interventions, incorporating plant extracts and isolated phytoconstituents. In the realm of pharmacological therapy for RA, specific disease-modifying antirheumatic drugs have showcased commendable efficacy. However, this conventional approach is not without its drawbacks, as it is often associated with various side effects. The integration of methodological strategies, encompassing both pharmacological and plant-based herbal therapies, presents a promising avenue for achieving substantive recovery. This integrated approach not only addresses the symptoms but also strives to tackle the underlying causes of RA, fostering a more comprehensive and sustainable path towards healing.
引用
收藏
页码:1705 / 1720
页数:16
相关论文
共 121 条
[1]
Biological basis for the use of botanicals in osteoarthritis and rheumatoid arthritis: A review [J].
Ahmed, S ;
Anuntiyo, J ;
Malemud, CJ ;
Haqqi, TM .
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2005, 2 (03) :301-308
[2]
Green tea polyphenol epigallocatechin 3-gallate in arthritis: progress and promise [J].
Ahmed, Salahuddin .
ARTHRITIS RESEARCH & THERAPY, 2010, 12 (02)
[3]
Traditional and modern management strategies for rheumatoid arthritis [J].
Akram, Muhammad ;
Daniyal, Muhammad ;
Sultana, Sabira ;
Owais, Aymen ;
Akhtar, Naheed ;
Zahid, Rabia ;
Said, Fahad ;
Bouyahya, Abdelhakim ;
Ponomarev, Evgeny ;
Shariat, Mohammad Ali ;
Thiruvengadam, Muthu .
CLINICA CHIMICA ACTA, 2021, 512 :142-155
[4]
Rheumatoid arthritis: Recent advances on its etiology, role of cytokines and pharmacotherapy [J].
Alam, Javaid ;
Jantan, Ibrahim ;
Bukhari, Syed Nasir Abbas .
BIOMEDICINE & PHARMACOTHERAPY, 2017, 92 :615-633
[5]
Alghuweri Ali., 2012, INT J BIOL MED RES, V3, P1397
[6]
Efficacy and safety of the human anti-IL-1beta monoclonal antibody canakinumab in rheumatoid arthritis: results of a 12-week, phase II, dose-finding study [J].
Alten, Rieke ;
Gomez-Reino, Juan ;
Durez, Patrick ;
Beaulieu, Andre ;
Sebba, Anthony ;
Krammer, Gerhard ;
Preiss, Ralph ;
Arulmani, Udayasankar ;
Widmer, Albert ;
Gitton, Xavier ;
Kellner, Herbert .
BMC MUSCULOSKELETAL DISORDERS, 2011, 12
[7]
Anand David Alexander Victor, 2016, Pharmacogn Rev, V10, P84, DOI [10.4103/0973-7847.194044, 10.4103/0973-7847.194044]
[8]
Anilkumar, 2010, ETHNOMEDICINE SOURCE, P267, DOI DOI 10.3389/FPHAR.2024.1366695
[9]
Askari G, 2012, J RES MED SCI, V17, P637
[10]
Risk factors for osteoporosis and fractures in rheumatoid arthritis [J].
Baker, Rahaf ;
Narla, Radhika ;
Baker, Joshua F. ;
Wysham, Katherine D. .
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2022, 36 (03)